Aging Clinical Trial
Official title:
Study on the Correlation Between Ovarian Function and Serum Biomarkers
The goal of this observational study is to find differences in serum biomarkers between ovarian function and normal individuals.
Status | Recruiting |
Enrollment | 35 |
Est. completion date | October 24, 2024 |
Est. primary completion date | October 24, 2024 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 18 Years to 45 Years |
Eligibility | Inclusion Criteria: 1. The selection criteria for healthy individuals are follows. - women aged 18-45. - Basic FSH<10IU/L, and AMH is within the normal range. - Regular menstruation. - Agree and sign an informed consent form. 2. The selection criteria for DOR patients are follows. - women aged 18-45. - For two consecutive menstrual cycles, 25 = basal FSH = 10IU/L or AMH<1.1ng/ml. - Agree and sign an informed consent form. 3. Selection criteria for POI patients are follows. - 18 = females aged <40 years old. - Two consecutive menstrual cycles with basal FSH>25IU/L or AMH<1.1ng/ml. - Agree and sign an informed consent form. Exclusion Criteria: 1. Patients with congenital gonadal developmental abnormalities or a family history similar to "early menopause". 2. Patients with acquired organic lesions or decreased ovarian function caused by ovarian surgery. 3. Patients who have undergone artificial cycle therapy with Western medicine or other endocrine treatments within the past three months. 4. Patients with severe primary diseases and mental disorders such as crdiovascular, cerebrovascular, liver, kidney, and hematopoietic system. 5. Patients during lactation or pregnancy. 6. Patients who are allergic to the drugs used in this study or have a history of allergic reactions to traditional Chinese medicine. Those who meet any of the above 5 criteria for DOR and POI will be excluded and not included in this study. The exclusion criteria for healthy subjects are as (1), (3), (4), and (5). |
Country | Name | City | State |
---|---|---|---|
China | Dongzhimen Hospital, Beijing University of Chinese Medicine | Beijing |
Lead Sponsor | Collaborator |
---|---|
Shi Yun |
China,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | copper | the level of copper in blood sample | On the 2~4th day of menstruation (amenorrhea patients before and after taking medication) | |
Primary | Iron ion | the level of Iron ion in blood sample | On the 2~4th day of menstruation (amenorrhea patients before and after taking medication) | |
Primary | ceruloplasmin, CP | the level of ceruloplasmin in blood sample | On the 2~4th day of menstruation (amenorrhea patients before and after taking medication) | |
Primary | CuZn-Superoxide Dismutase, CuZn-SOD/SOD1 | the level of CuZn-SOD/SOD1 in blood sample | On the 2~4th day of menstruation (amenorrhea patients before and after taking medication) | |
Primary | Malondialdehyde,MDA | the level of MDA in blood sample | On the 2~4th day of menstruation (amenorrhea patients before and after taking medication) | |
Secondary | other relative biomarkers about copper/iron metabolism and oxidative stress | depending on the results of the five biomarkers above | On the 2~4th day of menstruation (amenorrhea patients before and after taking medication) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05433233 -
Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension
|
N/A | |
Recruiting |
NCT06032065 -
Sequential Multiple Assessment Randomized Trial of Exercise for PAD: SMART Exercise for PAD (SMART PAD)
|
Phase 3 | |
Completed |
NCT05293730 -
Trial of the Impact of the Electronic Frailty Integrated With Social Needs
|
N/A | |
Recruiting |
NCT03932162 -
Gene Expression Changes In Young and Geriatric Skin
|
Early Phase 1 | |
Completed |
NCT04064528 -
Effects of Age on Amino Acid Delivery to Tendon
|
N/A | |
Completed |
NCT03366129 -
Blood-Brain Barrier Disruption in People With White Matter Hyperintensities Who Have Had a Stroke
|
||
Completed |
NCT06029920 -
Influence of Overground Walking on Biomarkers, Cognitive Function, and Quality of Life in Elderly With Mild Cognitive Impairment
|
N/A | |
Recruiting |
NCT05566938 -
Study to Design a Precision Nutrition Strategy at a Group Level in the Elderly
|
N/A | |
Recruiting |
NCT05543980 -
Leg Heat Therapy in Elderly Individuals
|
Phase 2 | |
Completed |
NCT04894929 -
Comprehensive Geriatric Assessment in the Monitoring of Functional Improvement
|
N/A | |
Not yet recruiting |
NCT06071130 -
Emotion, Aging, and Decision Making
|
N/A | |
Enrolling by invitation |
NCT04641663 -
Multi-target Dietary Supplement Tolerability in an Aging Population (MTDSST)
|
N/A | |
Completed |
NCT04088006 -
The Evaluation of Efficacy and Safety of Hyaluronic Acid Injection on Skin Moisturization and Elasticity
|
N/A | |
Completed |
NCT03695081 -
Patient Pathway Pharmacist - Optimal Drug-related Care
|
N/A | |
Recruiting |
NCT05424263 -
Acetate and Age-associated Arterial Dysfunction
|
Phase 2 | |
Completed |
NCT05601713 -
Mitigating Heat-induced Physiological Strain and Discomfort in Older Adults Via Lower Limb Immersion and Neck Cooling
|
N/A | |
Completed |
NCT04551339 -
Zinc Versus Multivitamin Micronutrient Supplementation in the Setting of COVID-19
|
N/A | |
Recruiting |
NCT04997577 -
Speech Perception and High Cognitive Demand
|
N/A | |
Completed |
NCT05922475 -
Efficacy of Pre-sleep or Post-exercise Protein During 12 Weeks of Resistance Exercise Training
|
N/A | |
Completed |
NCT04015479 -
Peanut Protein Supplementation to Augment Muscle Growth and Improve Markers of Muscle Quality and Health in Older Adults
|
N/A |